Meet the Team
Bernadette Porter MBE Clinical Lead NeuroResponse
& NIA Fellow
Bernadette is a Consultant MS Nurse at The National Hospital for Neurology and Neurosurgery, UCLH. She was awarded an MBE for services to nursing. Bernadette holds an MSc in Clinical Neuroscience and has published widely in academic journals. She is an advisor to a number of organisations including the RCN and RCP.
Bernadette has a track record of successfully and collaboratively challenging multidisciplinary teams to deliver patient focused care and is actively involved in service design and patient focused research agendas within UCL Partners.
Prizes awarded include The International MS Nurses Award for Excellence, British Journal of Nursing Award for Clinical Practice, the British Journal of Nursing Nurse of the Year included in the inaugural HSJ Top Innovators list in 2013 and winner of the Nursing Standard eHealth 2014.
Dr Jeremy Chataway Consultant Neurologist
Dr. Jeremy Chataway MA, PhD, FRCP Consultant Neurologist: National Hospital for Neurology and Neurosurgery, Queen Square, University College Foundation NHS Trust, London and St Mary’s Hospital (Imperial College Healthcare NHS Trust).
After qualifying in medicine at Cambridge and Oxford Universities, and general medical training in London, Dr. Chataway specialised in Neurology over an eight year period with posts in Edinburgh, Cambridge and London.
He was awarded a PhD from Cambridge University in genetic epidemiology of multiple sclerosis and took up his post as a consultant Neurologist in 2001 at St Mary’s Hospital (Imperial College Healthcare NHS Trust) and The National Hospital for Neurology and Neurosurgery, Queen Square, University College Foundation NHS Trust, London.
He has a particular interest in multiple sclerosis, in clinical trial work involving novel agents and advanced trial design, as well as service delivery.
Dr. Chataway currently sits on the MS Society Grant Review Panel for Care and Services Research and is a member of the Society’s Clinical Trials Network Steering Group.
Dr Robert Brenner Consultant Neurologist
Dr. Brenner is a highly experienced clinician having been a consultant neurologist for over 20 years. He combines the academic environment of the Royal Free hospital with the demands of a busy District General Hospital in West Herts. He is also an honorary Senior Lecturer at UCL and has a long involvement in MS research.
As the Lead Neurologist at RFH he has expertise in service design and is currently engaged in development of innovative reconfiguration of neurology provision with local CCGs.
He has been involved in the co-design of the NeuroResponse model contributing to the benchmark audit of Multiple Sclerosis service across the UCL partner region and the patient and family co-design events.
Kelly McClean Clinical Nurse Specialist
An honours nursing degree graduate from Galway-Mayo Institute of Technology Ireland, Kelly has worked as a registered nurse in the NHS for over 3 years. Experience to date includes caring for people in Elderly Care Units and Trauma & Orthopaedic departments.
Since 2015 Kelly has concentrated her work in the world renowned National Hospital for Neurology and Neurosurgery UCLH Foundation Trust developing expert skills in neuroscience nursing. Kelly’s passion to improve care for people living with long term neurological conditions such as Multiple Sclerosis, Dementia and Parkinson’s disease, as near to their homes as possible, prompted her to join the NeuroResponse service.
As a Lead Neurology Nurse, Kelly works closely with district nursing colleagues, GPs and community allied health professionals to create care plans for people with complex neurological health needs within their own homes. As a supporter of innovation in the NHS Kelly embraces and evaluates the use of digital technological systems that show potential to improve care for patients and their families and introduce new ways of staff working.
Ian Harris Commercial Advisor
Ian has over 30 years international experience in technology businesses, having held a range of commercial roles within Blue Chip and start-up organisations
Ian has extensive leadership, business management, sales and marketing experience in medical device, biotech and international regulated chemical markets.
From 2003 to 2010 Ian was CEO of Cambridge Cognition, a software-based, neuro-medical device company. Ian completely restructured the business, raised over £5m in equity from private and institutional investors, turned the business around and took it to profitability with a high growth trajectory. This put the business on a strong footing for its 2013 IPO. Ian is currently a director of a number of early stage businesses.
Professor Alan M. Palmer FRSB, PhD, MSc, BSc
Professor Alan Palmer has board level experience in several organisations. Currently, he is a non-executive director of One Nucleus Ltd (an international membership organisation for companies working within the life science and healthcare industry) and the British Neuroscience Association (the largest UK organisation representing and promoting neuroscience and neuroscientists). He is also a Trustee of The Brain Tumour Charity and one of the internationally recognised scientists that sits on the Welsh Government’s Sêr Cymru II Evaluation Panel.
Alan was one of the founders of the first UK neuroscience-based start-up company (Cerebrus Ltd, now Vernalis plc) and co-founded Pharmidex Pharmaceutical Services Ltd, a successful contract research organisation working in the medicines research arena. He was voted London Biotechnology Network Entrepreneur of the Year in 2005.
Alan is a visiting Professor at University College London and the University of Reading and Life Science Entrepreneur in Residence at the University of Bristol. He is also a Fellow of the Royal Society of Biology and an Honorary member of the Society for Medicines Research.
Alan has a BSc in Biochemistry from Warwick University, an MSc from Kings College London (Institute of Psychiatry) and a PhD from University College London (Institute of Neurology).